| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.863 | 0.004 | 0.863 | Aldehyde oxidase inhibitor | 0.171 0.122 CID_54264794 | ||
| 0.802 | 0.003 | 0.802 | Alcohol oxidase inhibitor | 0.095 0.019 CID_54264794 | ||
| 0.745 | 0.018 | 0.745 | Caspase 9 stimulant | 0.717 0.022 CID_54264794 | ||
| 0.721 | 0.003 | 0.721 | Peroxidase inhibitor | 0.133 0.089 CID_54264794 | ||
| 0.71 | 0.006 | 0.71 | 5 Hydroxytryptamine release stimulant | 0.55 0.02 CID_54264794 | ||
| 0.692 | 0.003 | 0.692 | GABA C receptor rho-3 antagonist | |||
| 0.636 | 0.005 | 0.636 | Superoxide dismutase inhibitor | |||
| 0.623 | 0.008 | 0.693 | 5 Hydroxytryptamine release inhibitor | 0.693 0.004 CID_54264794 | CID_54264794 | |
| 0.608 | 0.003 | 0.608 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.572 | 0.009 | 0.572 | Calcium channel L-type activator | 0.244 0.212 CID_54264794 | ||
| 0.559 | 0.003 | 0.559 | Estrogen receptor beta antagonist | |||
| 0.551 | 0.004 | 0.551 | Estrogen antagonist | 0.107 0.08 CID_54264794 | ||
| 0.559 | 0.015 | 0.689 | Histamine release inhibitor | 0.689 0.005 CID_54264794 | CID_54264794 | |
| 0.557 | 0.024 | 0.735 | Cholesterol antagonist | 0.735 0.006 CID_54264794 | CID_54264794 | |
| 0.525 | 0.014 | 0.696 | Free radical scavenger | 0.696 0.005 CID_54264794 | CID_54264794 | |
| 0.514 | 0.019 | 0.756 | Antioxidant | 0.756 0.005 CID_54264794 | CID_54264794 | |
| 0.499 | 0.004 | 0.499 | 5 Hydroxytryptamine uptake stimulant | 0.229 0.105 CID_54264794 | ||
| 0.497 | 0.004 | 0.497 | Cystathionine beta-synthase inhibitor | 0.413 0.005 CID_54264794 | ||
| 0.495 | 0.005 | 0.72 | Alpha-N-acetylglucosaminidase inhibitor | 0.72 0.003 CID_54264794 | CID_54264794 | |
| 0.468 | 0.004 | 0.468 | Porphobilinogen synthase inhibitor | |||
| 0.473 | 0.017 | 0.473 | Amyloid beta aggregation inhibitor | 0.207 0.074 CID_54264794 | ||
| 0.447 | 0.003 | 0.447 | Creatine kinase inhibitor | 0.118 0.042 CID_54264794 | ||
| 0.484 | 0.041 | 0.484 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.436 | 0.004 | 0.436 | GABA C receptor agonist | 0.115 0.053 CID_54264794 | ||
| 0.434 | 0.003 | 0.434 | Phenylalanine 4-hydroxylase inhibitor | 0.077 0.04 CID_54264794 | ||
| 0.434 | 0.004 | 0.434 | Estrogen agonist | 0.102 0.017 CID_54264794 | ||
| 0.498 | 0.075 | 0.694 | Apoptosis agonist | 0.694 0.032 CID_54264794 | CID_54264794 | |
| 0.451 | 0.029 | 0.451 | Caspase 3 stimulant | 0.42 0.039 CID_54264794 | ||
| 0.432 | 0.015 | 0.432 | Calcium channel activator | 0.23 0.171 CID_54264794 | ||
| 0.413 | 0.005 | 0.413 | Aldehyde dehydrogenase inhibitor | 0.355 0.007 CID_54264794 | ||
| 0.413 | 0.005 | 0.426 | Neurotrophic factor enhancer | 0.426 0.005 CID_54264794 | CID_54264794 | |
| 0.454 | 0.053 | 0.454 | 15-Lipoxygenase inhibitor | |||
| 0.43 | 0.032 | 0.43 | 12-Lipoxygenase inhibitor | |||
| 0.436 | 0.045 | 0.436 | Vasodilator, peripheral | 0.412 0.051 CID_54264794 | ||
| 0.401 | 0.016 | 0.401 | Anesthetic general | 0.381 0.019 CID_54264794 | ||
| 0.39 | 0.009 | 0.39 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.323 0.017 CID_54264794 | ||
| 0.387 | 0.009 | 0.474 | NOS3 expression enhancer | 0.474 0.005 CID_54264794 | CID_54264794 | |
| 0.394 | 0.019 | 0.394 | Sodium/bile acid cotransporter inhibitor | 0.289 0.089 CID_54264794 | ||
| 0.375 | 0.005 | 0.375 | Succinate dehydrogenase inhibitor | 0.207 0.044 CID_54264794 | ||
| 0.427 | 0.058 | 0.725 | Transcription factor NF kappa B inhibitor | 0.725 0.018 CID_54264794 | CID_54264794 | |
| 0.389 | 0.024 | 0.389 | Sigma receptor agonist | |||
| 0.372 | 0.011 | 0.704 | Amylase inhibitor | 0.704 0.003 CID_54264794 | CID_54264794 | |
| 0.384 | 0.024 | 0.384 | Pyruvate kinase inhibitor | |||
| 0.363 | 0.004 | 0.363 | Histidine decarboxylase inhibitor | |||
| 0.389 | 0.033 | 0.422 | Hypoxia-inducible factor 1 alpha inhibitor | 0.422 0.025 CID_54264794 | CID_54264794 | |
| 0.369 | 0.022 | 0.369 | RNA-directed DNA polymerase inhibitor | 0.291 0.033 CID_54264794 | ||
| 0.351 | 0.003 | 0.351 | Estrogen receptor beta agonist | 0.058 0.018 CID_54264794 | ||
| 0.355 | 0.008 | 0.49 | UDP-glucose 4-epimerase inhibitor | 0.49 0.003 CID_54264794 | CID_54264794 | |
| 0.387 | 0.041 | 0.387 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.386 | 0.04 | 0.386 | Aryl hydrocarbon receptor agonist | |||
| 0.348 | 0.004 | 0.348 | GABA C receptor rho-2 antagonist | |||
| 0.381 | 0.042 | 0.381 | Lipoxygenase inhibitor | |||
| 0.353 | 0.016 | 0.543 | Melanin inhibitor | 0.543 0.005 CID_54264794 | CID_54264794 | |
| 0.364 | 0.03 | 0.364 | Insulysin inhibitor | |||
| 0.338 | 0.009 | 0.338 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.334 | 0.006 | 0.334 | Carbonic anhydrase XV inhibitor | |||
| 0.373 | 0.055 | 0.373 | Streptokinase A inhibitor | |||
| 0.356 | 0.038 | 0.356 | Interleukin antagonist | |||
| 0.322 | 0.005 | 0.322 | Carbonic anhydrase III inhibitor | 0.191 0.018 CID_54264794 | ||
| 0.322 | 0.007 | 0.322 | Nitric-oxide synthase stimulant | 0.32 0.008 CID_54264794 | ||
| 0.329 | 0.016 | 0.329 | Phospholipase C inhibitor | 0.238 0.028 CID_54264794 | ||
| 0.349 | 0.036 | 0.349 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.315 | 0.008 | 0.315 | Interleukin 4 antagonist | 0.193 0.024 CID_54264794 | ||
| 0.321 | 0.016 | 0.42 | Lipid peroxidase inhibitor | 0.42 0.009 CID_54264794 | CID_54264794 | |
| 0.357 | 0.052 | 0.554 | Vasodilator, coronary | 0.554 0.01 CID_54264794 | CID_54264794 | |
| 0.334 | 0.03 | 0.489 | Cyclic AMP phosphodiesterase inhibitor | 0.489 0.007 CID_54264794 | CID_54264794 | |
| 0.335 | 0.033 | 0.492 | Interleukin agonist | 0.492 0.009 CID_54264794 | CID_54264794 | |
| 0.301 | 0.004 | 0.301 | GABA C receptor antagonist | |||
| 0.335 | 0.04 | 0.335 | Transcription factor STAT inhibitor | |||
| 0.297 | 0.004 | 0.297 | Estrogen receptor alpha agonist | |||
| 0.349 | 0.056 | 0.593 | Apoptosis antagonist | 0.593 0.01 CID_54264794 | CID_54264794 | |
| 0.302 | 0.01 | 0.302 | 5-Lipoxygenase inhibitor | |||
| 0.302 | 0.012 | 0.302 | NADPH oxidase inhibitor | 0.229 0.026 CID_54264794 | ||
| 0.289 | 0.004 | 0.289 | CF transmembrane conductance regulator agonist | 0.215 0.015 CID_54264794 | ||
| 0.292 | 0.008 | 0.292 | Ferrochelatase inhibitor | |||
| 0.287 | 0.004 | 0.287 | Macrophage migration inhibitory factor inhibitor | |||
| 0.325 | 0.044 | 0.325 | Dyrk kinase inhibitor | |||
| 0.285 | 0.005 | 0.285 | Alcohol dehydrogenase inhibitor | 0.217 0.01 CID_54264794 | ||
| 0.297 | 0.018 | 0.376 | Topoisomerase II inhibitor | 0.376 0.011 CID_54264794 | CID_54264794 | |
| 0.305 | 0.026 | 0.305 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.315 | 0.039 | 0.477 | DNA synthesis inhibitor | 0.477 0.015 CID_54264794 | CID_54264794 | |
| 0.283 | 0.007 | 0.298 | Mannose-6-phosphate isomerase inhibitor | 0.298 0.005 CID_54264794 | CID_54264794 | |
| 0.287 | 0.012 | 0.446 | Hexokinase inhibitor | 0.446 0.004 CID_54264794 | CID_54264794 | |
| 0.28 | 0.007 | 0.383 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.383 0.004 CID_54264794 | CID_54264794 | |
| 0.321 | 0.05 | 0.353 | DNA damaging | 0.353 0.04 CID_54264794 | CID_54264794 | |
| 0.276 | 0.005 | 0.505 | Triose-phosphate isomerase inhibitor | 0.505 0.002 CID_54264794 | CID_54264794 | |
| 0.316 | 0.046 | 0.316 | Transcription factor STAT3 inhibitor | |||
| 0.273 | 0.003 | 0.273 | DOPA decarboxylase inhibitor | 0.107 0.063 CID_54264794 | ||
| 0.273 | 0.004 | 0.273 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.287 | 0.019 | 0.574 | Monophenol monooxygenase inhibitor | 0.574 0.005 CID_54264794 | CID_54264794 | |
| 0.28 | 0.013 | 0.28 | Chelator | |||
| 0.27 | 0.009 | 0.27 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.267 | 0.008 | 0.267 | Carbonic anhydrase VI inhibitor | 0.113 0.032 CID_54264794 | ||
| 0.354 | 0.099 | 0.668 | Antibacterial | 0.668 0.011 CID_54264794 | CID_54264794 | |
| 0.306 | 0.051 | 0.766 | Hypoglycemic | 0.766 0.004 CID_54264794 | CID_54264794 | |
| 0.377 | 0.124 | 0.636 | Alpha-glucosidase inhibitor | 0.636 0.046 CID_54264794 | CID_54264794 | |
| 0.255 | 0.004 | 0.255 | Prolactin inhibitor | |||
| 0.255 | 0.005 | 0.255 | 5 Hydroxytryptamine 3A agonist | |||
| 0.254 | 0.004 | 0.254 | GABA C receptor rho-1 antagonist | |||
| 0.393 | 0.143 | 0.843 | Antiinflammatory | 0.843 0.01 CID_54264794 | CID_54264794 | |
| 0.257 | 0.008 | 0.257 | Toll-Like receptor 2 antagonist | 0.127 0.071 CID_54264794 | ||
| 0.252 | 0.004 | 0.252 | Glutamate decarboxylase inhibitor | |||
| 0.268 | 0.022 | 0.449 | Protein kinase stimulant | 0.449 0.005 CID_54264794 | CID_54264794 | |
| 0.267 | 0.021 | 0.267 | Heat shock protein 90 alpha antagonist | |||
| 0.269 | 0.025 | 0.442 | Interferon gamma antagonist | 0.442 0.009 CID_54264794 | CID_54264794 | |
| 0.276 | 0.036 | 0.369 | DNA methyltransferase I inhibitor | 0.369 0.012 CID_54264794 | CID_54264794 | |
| 0.284 | 0.045 | 0.284 | Gastrin inhibitor | 0.249 0.08 CID_54264794 | ||
| 0.272 | 0.035 | 0.547 | Non-steroidal antiinflammatory agent | 0.547 0.005 CID_54264794 | CID_54264794 | |
| 0.305 | 0.068 | 0.421 | Spasmolytic | 0.421 0.036 CID_54264794 | CID_54264794 | |
| 0.25 | 0.014 | 0.406 | ATPase inhibitor | 0.406 0.004 CID_54264794 | CID_54264794 | |
| 0.24 | 0.006 | 0.24 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.239 | 0.005 | 0.239 | Keratolytic | |||
| 0.245 | 0.012 | 0.245 | Catenin beta inhibitor | |||
| 0.241 | 0.008 | 0.46 | NADH dehydrogenase inhibitor | 0.46 0.004 CID_54264794 | CID_54264794 | |
| 0.243 | 0.011 | 0.28 | Topoisomerase II alpha inhibitor | 0.28 0.008 CID_54264794 | CID_54264794 | |
| 0.252 | 0.02 | 0.252 | Heat shock protein 90 antagonist | |||
| 0.255 | 0.025 | 0.255 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.236 | 0.007 | 0.35 | Photosensitizer | 0.35 0.004 CID_54264794 | CID_54264794 | |
| 0.25 | 0.021 | 0.25 | Neurotensin receptor agonist | |||
| 0.232 | 0.005 | 0.232 | Adenylate cyclase stimulant | 0.169 0.036 CID_54264794 | ||
| 0.284 | 0.057 | 0.383 | Antiamyloidogenic | 0.383 0.032 CID_54264794 | CID_54264794 | |
| 0.275 | 0.05 | 0.285 | Psychostimulant | 0.285 0.047 CID_54264794 | CID_54264794 | |
| 0.233 | 0.009 | 0.233 | Potassium channel (Ca-activated) activator | |||
| 0.298 | 0.075 | 0.491 | Interleukin 2 agonist | 0.491 0.009 CID_54264794 | CID_54264794 | |
| 0.306 | 0.084 | 0.731 | Antithrombotic | 0.731 0.007 CID_54264794 | CID_54264794 | |
| 0.233 | 0.01 | 0.233 | Arachidonic acid antagonist | 0.187 0.046 CID_54264794 | ||
| 0.226 | 0.003 | 0.226 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.225 | 0.003 | 0.225 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.267 | 0.047 | 0.267 | MAP kinase kinase 2 inhibitor | |||
| 0.226 | 0.007 | 0.226 | TRPA1 agonist | 0.148 0.032 CID_54264794 | ||
| 0.226 | 0.007 | 0.226 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.263 | 0.045 | 0.263 | Neuropeptide Y2 antagonist | |||
| 0.26 | 0.043 | 0.382 | DNA methylase inhibitor | 0.382 0.012 CID_54264794 | CID_54264794 | |
| 0.222 | 0.007 | 0.222 | Estrogen receptor alpha antagonist | |||
| 0.226 | 0.012 | 0.226 | Adenylate kinase inhibitor | 0.179 0.018 CID_54264794 | ||
| 0.238 | 0.024 | 0.238 | Cyclooxygenase 1 inhibitor | 0.121 0.079 CID_54264794 | ||
| 0.228 | 0.015 | 0.339 | Xanthine oxidase inhibitor | 0.339 0.005 CID_54264794 | CID_54264794 | |
| 0.233 | 0.02 | 0.233 | Cholesterol synthesis inhibitor | 0.167 0.037 CID_54264794 | ||
| 0.244 | 0.032 | 0.244 | Protein-tyrosine phosphatase inhibitor | 0.193 0.049 CID_54264794 | ||
| 0.241 | 0.03 | 0.241 | Histone acetyltransferase inhibitor | |||
| 0.221 | 0.011 | 0.228 | Carbonic anhydrase XIII inhibitor | 0.228 0.011 CID_54264794 | CID_54264794 | |
| 0.223 | 0.016 | 0.223 | Farnesoid X receptor antagonist | |||
| 0.244 | 0.038 | 0.244 | Insulin sensitizer | 0.24 0.04 CID_54264794 | ||
| 0.205 | 0.002 | 0.205 | Dopamine D5 agonist | |||
| 0.246 | 0.044 | 0.246 | Growth hormone agonist | |||
| 0.252 | 0.051 | 0.538 | Nitric oxide antagonist | 0.538 0.013 CID_54264794 | CID_54264794 | |
| 0.242 | 0.043 | 0.242 | Dual specificity phosphatase 3 inhibitor | |||
| 0.221 | 0.022 | 0.329 | Topoisomerase I inhibitor | 0.329 0.009 CID_54264794 | CID_54264794 | |
| 0.202 | 0.006 | 0.211 | Heat shock protein 70 antagonist | 0.211 0.005 CID_54264794 | CID_54264794 | |
| 0.306 | 0.11 | 0.306 | Calpain 2 inhibitor | |||
| 0.206 | 0.012 | 0.206 | MAP kinase kinase 4 inhibitor | |||
| 0.234 | 0.042 | 0.234 | Dual specificity phosphatase inhibitor | |||
| 0.204 | 0.012 | 0.581 | Beta glucuronidase inhibitor | 0.581 0.003 CID_54264794 | CID_54264794 | |
| 0.194 | 0.003 | 0.194 | D-Ala-D-Ala ligase inhibitor | |||
| 0.231 | 0.041 | 0.231 | Amyloid beta precursor protein antagonist | |||
| 0.232 | 0.042 | 0.232 | Mcl-1 antagonist | |||
| 0.193 | 0.004 | 0.193 | Ca2+-transporting ATPase inhibitor | 0.187 0.005 CID_54264794 | ||
| 0.2 | 0.013 | 0.2 | Interleukin 8 antagonist | |||
| 0.201 | 0.015 | 0.201 | Catalase inhibitor | |||
| 0.198 | 0.012 | 0.198 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.203 | 0.018 | 0.554 | Cyclooxygenase 3 inhibitor | 0.554 0.003 CID_54264794 | CID_54264794 | |
| 0.253 | 0.069 | 0.854 | Angiogenesis stimulant | 0.854 0.003 CID_54264794 | CID_54264794 | |
| 0.213 | 0.029 | 0.22 | Alkaline phosphatase inhibitor | 0.22 0.027 CID_54264794 | CID_54264794 | |
| 0.29 | 0.106 | 0.29 | Prostaglandin dehydrogenase inhibitor | |||
| 0.197 | 0.015 | 0.197 | Protein kinase C gamma inhibitor | |||
| 0.206 | 0.024 | 0.206 | Adenylate cyclase inhibitor | 0.137 0.054 CID_54264794 | ||
| 0.23 | 0.049 | 0.23 | I kappa B kinase epsilon inhibitor | |||
| 0.208 | 0.027 | 0.403 | Cell wall synthesis inhibitor | 0.403 0.006 CID_54264794 | CID_54264794 | |
| 0.193 | 0.012 | 0.193 | Protein kinase C zeta inhibitor | |||
| 0.191 | 0.012 | 0.323 | Phosphofructokinase-1 inhibitor | 0.323 0.005 CID_54264794 | CID_54264794 | |
| 0.207 | 0.028 | 0.207 | MAO A inhibitor | |||
| 0.207 | 0.029 | 0.207 | Death-associated protein kinase 2 inhibitor | |||
| 0.214 | 0.037 | 0.214 | MAO inhibitor | |||
| 0.192 | 0.015 | 0.204 | Mucolytic | 0.204 0.013 CID_54264794 | CID_54264794 | |
| 0.18 | 0.004 | 0.18 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.235 | 0.062 | 0.456 | Peptidyltransferase inhibitor | 0.456 0.004 CID_54264794 | CID_54264794 | |
| 0.178 | 0.005 | 0.197 | Glutamate release inhibitor | 0.197 0.005 CID_54264794 | CID_54264794 | |
| 0.183 | 0.011 | 0.183 | HIV-1 integrase (3'-Processing) inhibitor | 0.073 0.037 CID_54264794 | ||
| 0.193 | 0.023 | 0.193 | Aminopeptidase B inhibitor | |||
| 0.173 | 0.003 | 0.173 | Estrogen-related receptor beta agonist | |||
| 0.173 | 0.005 | 0.173 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.26 | 0.092 | 0.54 | Immunostimulant | 0.54 0.024 CID_54264794 | CID_54264794 | |
| 0.213 | 0.046 | 0.213 | Tumour necrosis factor antagonist | |||
| 0.171 | 0.005 | 0.171 | GABA aminotransferase inhibitor | 0.152 0.008 CID_54264794 | ||
| 0.189 | 0.023 | 0.189 | Nav1.6 sodium channel blocker | |||
| 0.204 | 0.039 | 0.31 | Interleukin 6 antagonist | 0.31 0.013 CID_54264794 | CID_54264794 | |
| 0.261 | 0.096 | 0.261 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.181 | 0.017 | 0.181 | NMDA receptor antagonist | |||
| 0.187 | 0.023 | 0.512 | Expectorant | 0.512 0.004 CID_54264794 | CID_54264794 | |
| 0.194 | 0.031 | 0.194 | Protein-tyrosine phosphatase 1B inhibitor | 0.192 0.031 CID_54264794 | ||
| 0.175 | 0.012 | 0.175 | NMDA 2 receptor antagonist | |||
| 0.169 | 0.007 | 0.169 | Carbonic anhydrase VB inhibitor | |||
| 0.17 | 0.009 | 0.17 | Potassium channel large-conductance Ca-activated activator | |||
| 0.165 | 0.004 | 0.165 | GABA B receptor agonist | |||
| 0.168 | 0.007 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.197 | 0.036 | 0.197 | Bone formation stimulant | 0.134 0.073 CID_54264794 | ||
| 0.171 | 0.012 | 0.171 | CYP2A6 inhibitor | |||
| 0.176 | 0.017 | 0.214 | Uric acid excretion stimulant | 0.214 0.011 CID_54264794 | CID_54264794 | |
| 0.171 | 0.012 | 0.171 | Transcription factor STAT6 inhibitor | |||
| 0.172 | 0.013 | 0.172 | Opioid kappa receptor antagonist | |||
| 0.236 | 0.078 | 0.236 | Calpain inhibitor | |||
| 0.184 | 0.027 | 0.184 | Cathepsin H inhibitor | |||
| 0.177 | 0.021 | 0.177 | Pregnane X receptor agonist | |||
| 0.18 | 0.024 | 0.18 | Falcipain 3 inhibitor | |||
| 0.175 | 0.019 | 0.175 | Opioid antagonist | |||
| 0.161 | 0.005 | 0.161 | NMDA receptor subunit 3B antagonist | |||
| 0.173 | 0.018 | 0.173 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.171 | 0.017 | 0.171 | Sphingomyelinase inhibitor | 0.159 0.021 CID_54264794 | ||
| 0.197 | 0.043 | 0.197 | Cyclooxygenase inhibitor | 0.119 0.101 CID_54264794 | ||
| 0.193 | 0.039 | 0.193 | Tubulin antagonist | |||
| 0.171 | 0.017 | 0.507 | AMP-activated protein kinase stimulant | 0.507 0.003 CID_54264794 | CID_54264794 | |
| 0.164 | 0.012 | 0.164 | Anabolic | 0.105 0.056 CID_54264794 | ||
| 0.169 | 0.016 | 0.169 | Opioid delta receptor antagonist | |||
| 0.158 | 0.006 | 0.158 | Purinergic P2X1 antagonist | 0.09 0.02 CID_54264794 | ||
| 0.156 | 0.005 | 0.156 | Topoisomerase II beta inhibitor | 0.11 0.008 CID_54264794 | ||
| 0.172 | 0.022 | 0.172 | Vanilloid 1 agonist | 0.157 0.032 CID_54264794 | ||
| 0.162 | 0.012 | 0.162 | Carbonic anhydrase V inhibitor | |||
| 0.156 | 0.006 | 0.156 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.154 0.006 CID_54264794 | ||
| 0.195 | 0.046 | 0.195 | Phospholipase A2 inhibitor | 0.166 0.062 CID_54264794 | ||
| 0.168 | 0.019 | 0.364 | DNA repair enzyme inhibitor | 0.364 0.004 CID_54264794 | CID_54264794 | |
| 0.163 | 0.015 | 0.163 | Electrolyte absorption antagonist | |||
| 0.158 | 0.01 | 0.158 | Myeloperoxidase inhibitor | |||
| 0.169 | 0.022 | 0.169 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.161 | 0.014 | 0.161 | Glutamate dehydrogenase inhibitor | 0.113 0.025 CID_54264794 | ||
| 0.18 | 0.033 | 0.18 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.157 | 0.012 | 0.157 | Histamine N-methyltransferase inhibitor | |||
| 0.15 | 0.009 | 0.15 | NMDA 2B receptor antagonist | |||
| 0.148 | 0.007 | 0.148 | Glycine receptor agonist | 0.129 0.01 CID_54264794 | ||
| 0.144 | 0.004 | 0.144 | Aconitate hydratase inhibitor | 0.054 0.032 CID_54264794 | ||
| 0.203 | 0.063 | 0.591 | Hepatoprotectant | 0.591 0.005 CID_54264794 | CID_54264794 | |
| 0.153 | 0.014 | 0.153 | Adrenaline agonist | |||
| 0.147 | 0.01 | 0.147 | Biliverdin reductase inhibitor | 0.102 0.018 CID_54264794 | ||
| 0.153 | 0.017 | 0.153 | Opioid mu receptor antagonist | |||
| 0.156 | 0.02 | 0.156 | Urease inhibitor | |||
| 0.146 | 0.012 | 0.146 | Carbonic anhydrase VA inhibitor | |||
| 0.166 | 0.032 | 0.166 | MAO B inhibitor | |||
| 0.139 | 0.006 | 0.139 | CD45 antagonist | |||
| 0.137 | 0.005 | 0.137 | CC chemokine 5 receptor agonist | |||
| 0.144 | 0.013 | 0.144 | HIV-1 integrase (Strand Transfer) inhibitor | 0.067 0.037 CID_54264794 | ||
| 0.14 | 0.01 | 0.14 | HIV-1 integrase inhibitor | |||
| 0.142 | 0.012 | 0.142 | Carbamoyl phosphate synthetase inhibitor | 0.085 0.026 CID_54264794 | ||
| 0.138 | 0.009 | 0.166 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.166 0.008 CID_54264794 | CID_54264794 | |
| 0.194 | 0.065 | 0.194 | LIM domain kinase 1 inhibitor | |||
| 0.139 | 0.011 | 0.139 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.167 | 0.038 | 0.327 | Alkylator | 0.327 0.011 CID_54264794 | CID_54264794 | |
| 0.138 | 0.011 | 0.138 | Alpha tubulin antagonist | |||
| 0.131 | 0.004 | 0.131 | Glutamate (mGluR7) antagonist | |||
| 0.167 | 0.041 | 0.185 | DNA polymerase I inhibitor | 0.185 0.033 CID_54264794 | CID_54264794 | |
| 0.159 | 0.033 | 0.215 | Microtubule formation inhibitor | 0.215 0.017 CID_54264794 | CID_54264794 | |
| 0.14 | 0.014 | 0.14 | Aminopeptidase I inhibitor | |||
| 0.147 | 0.023 | 0.198 | Toll-Like receptor 4 antagonist | 0.198 0.006 CID_54264794 | CID_54264794 | |
| 0.137 | 0.014 | 0.212 | Phosphodiesterase 6D inhibitor | 0.212 0.004 CID_54264794 | CID_54264794 | |
| 0.133 | 0.009 | 0.133 | Xanthine dehydrogenase inhibitor | 0.067 0.034 CID_54264794 | ||
| 0.127 | 0.004 | 0.127 | MAP kinase kinase 7 inhibitor | |||
| 0.166 | 0.043 | 0.166 | Neuropeptide Y1 antagonist | |||
| 0.129 | 0.006 | 0.129 | NMDA receptor subunit 3A antagonist | |||
| 0.262 | 0.139 | 0.562 | Immunosuppressant | 0.562 0.018 CID_54264794 | CID_54264794 | |
| 0.143 | 0.021 | 0.152 | Acetylcholine release stimulant | 0.152 0.015 CID_54264794 | CID_54264794 | |
| 0.145 | 0.024 | 0.145 | Androgen antagonist | |||
| 0.178 | 0.058 | 0.178 | Cytidine deaminase inhibitor | |||
| 0.175 | 0.054 | 0.175 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.141 | 0.021 | 0.141 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.133 | 0.013 | 0.133 | Argininosuccinate synthase inhibitor | 0.092 0.021 CID_54264794 | ||
| 0.214 | 0.094 | 0.421 | Vasodilator | 0.421 0.02 CID_54264794 | CID_54264794 | |
| 0.137 | 0.018 | 0.147 | Interleukin 12 antagonist | 0.147 0.013 CID_54264794 | CID_54264794 | |
| 0.132 | 0.013 | 0.186 | Glycine receptor antagonist | 0.186 0.004 CID_54264794 | CID_54264794 | |
| 0.29 | 0.172 | 0.867 | Cyclophilin D inhibitor | 0.867 0.005 CID_54264794 | CID_54264794 | |
| 0.129 | 0.013 | 0.129 | Bile acid receptor antagonist | 0.095 0.061 CID_54264794 | ||
| 0.166 | 0.051 | 0.492 | Hemostatic | 0.492 0.004 CID_54264794 | CID_54264794 | |
| 0.167 | 0.053 | 0.167 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.13 | 0.015 | 0.13 | Beta tubulin antagonist | |||
| 0.124 | 0.01 | 0.124 | NMDA 2C receptor antagonist | |||
| 0.14 | 0.028 | 0.14 | Breast cancer-resistant protein inhibitor | |||
| 0.116 | 0.004 | 0.116 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.119 | 0.007 | 0.119 | Heat shock protein 90 beta antagonist | |||
| 0.118 | 0.007 | 0.118 | Fatty acid synthase inhibitor | 0.059 0.037 CID_54264794 | ||
| 0.144 | 0.033 | 0.144 | Caspase 3 inhibitor | |||
| 0.134 | 0.023 | 0.166 | Thioredoxin inhibitor | 0.166 0.013 CID_54264794 | CID_54264794 | |
| 0.169 | 0.059 | 0.169 | Acetylcholine M1 receptor antagonist | |||
| 0.119 | 0.01 | 0.119 | NMDA 2A receptor antagonist | |||
| 0.119 | 0.01 | 0.119 | Beta 3 adrenoreceptor antagonist | |||
| 0.143 | 0.034 | 0.169 | CC chemokine 6 receptor antagonist | 0.169 0.008 CID_54264794 | CID_54264794 | |
| 0.11 | 0.002 | 0.11 | Estrogen-related receptor beta antagonist | |||
| 0.114 | 0.007 | 0.114 | Glutamate (mGluR6) antagonist | 0.078 0.027 CID_54264794 | ||
| 0.128 | 0.021 | 0.128 | Ornithine decarboxylase inhibitor | 0.106 0.037 CID_54264794 | ||
| 0.143 | 0.036 | 0.143 | Nav1.1 sodium channel blocker | |||
| 0.119 | 0.013 | 0.119 | Acyl-CoA dehydrogenase inhibitor | 0.063 0.031 CID_54264794 | ||
| 0.126 | 0.02 | 0.126 | Glutathione S-transferase inhibitor | 0.075 0.071 CID_54264794 | ||
| 0.151 | 0.045 | 0.151 | Antibacterial (Helicobacter pylori) | |||
| 0.111 | 0.005 | 0.111 | Sphingosine kinase 2 inhibitor | |||
| 0.197 | 0.092 | 0.197 | ErbB-1 antagonist | |||
| 0.114 | 0.008 | 0.114 | Phospholipase D inhibitor | |||
| 0.121 | 0.017 | 0.121 | mTOR complex 2 inhibitor | |||
| 0.157 | 0.053 | 0.157 | Nav1.2 sodium channel blocker | |||
| 0.12 | 0.018 | 0.12 | Aromatase inhibitor | |||
| 0.114 | 0.012 | 0.114 | CDC25B inhibitor | |||
| 0.129 | 0.027 | 0.129 | MAP kinase kinase 1 inhibitor | |||
| 0.116 | 0.015 | 0.133 | Aldose reductase inhibitor | 0.133 0.012 CID_54264794 | CID_54264794 | |
| 0.122 | 0.022 | 0.122 | Analgesic, opioid | |||
| 0.144 | 0.045 | 0.168 | Beta amyloid protein antagonist | 0.168 0.029 CID_54264794 | CID_54264794 | |
| 0.103 | 0.004 | 0.103 | Alpha 1d adrenoreceptor agonist | |||
| 0.132 | 0.033 | 0.132 | Antineoplastic alkaloid | |||
| 0.135 | 0.037 | 0.135 | Bronchodilator | |||
| 0.107 | 0.01 | 0.107 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.101 | 0.004 | 0.101 | Adenylate cyclase 1 inhibitor | |||
| 0.149 | 0.052 | 0.149 | MAP kinase kinase inhibitor | |||
| 0.163 | 0.067 | 0.163 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.161 | 0.065 | 0.161 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.162 | 0.067 | 0.344 | Diuretic | 0.344 0.017 CID_54264794 | CID_54264794 | |
| 0.149 | 0.055 | 0.149 | Cyclooxygenase 2 inhibitor | |||
| 0.202 | 0.108 | 0.537 | Tumour necrosis factor alpha release inhibitor | 0.537 0.011 CID_54264794 | CID_54264794 | |
| 0.098 | 0.005 | 0.098 | Dihydroorotate oxidase inhibitor | |||
| 0.191 | 0.098 | 0.191 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.144 | 0.052 | 0.144 | Anesthetic local | |||
| 0.112 | 0.02 | 0.112 | Leukotriene synthesis inhibitor | |||
| 0.099 | 0.007 | 0.099 | Transcription factor RelA inhibitor | |||
| 0.158 | 0.066 | 0.414 | Insulin secretagoues | 0.414 0.006 CID_54264794 | CID_54264794 | |
| 0.102 | 0.01 | 0.102 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.113 | 0.021 | 0.113 | Dopamine D1 antagonist | |||
| 0.113 | 0.021 | 0.113 | CDC25A inhibitor | |||
| 0.117 | 0.025 | 0.117 | Somatostatin 1 agonist | |||
| 0.131 | 0.039 | 0.346 | Mediator release inhibitor | 0.346 0.005 CID_54264794 | CID_54264794 | |
| 0.183 | 0.091 | 0.183 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.12 | 0.03 | 0.12 | Glutamate (mGluR7) agonist | |||
| 0.095 | 0.004 | 0.095 | Dopamine beta hydroxylase inhibitor | |||
| 0.103 | 0.012 | 0.103 | Protein kinase C beta inhibitor | |||
| 0.096 | 0.006 | 0.096 | Squalene epoxidase inhibitor | 0.049 0.036 CID_54264794 | ||
| 0.155 | 0.064 | 0.155 | Thiol protease inhibitor | |||
| 0.167 | 0.077 | 0.167 | Antipruritic | |||
| 0.1 | 0.011 | 0.147 | Carbonic anhydrase XIV inhibitor | 0.147 0.005 CID_54264794 | CID_54264794 | |
| 0.094 | 0.005 | 0.094 | Ryanodine receptor antagonist | |||
| 0.094 | 0.005 | 0.144 | Glucose-6-phosphate isomerase inhibitor | 0.144 0.003 CID_54264794 | CID_54264794 | |
| 0.148 | 0.059 | 0.148 | Interleukin 1 antagonist | |||
| 0.11 | 0.022 | 0.11 | Lipase inhibitor | 0.063 0.061 CID_54264794 | ||
| 0.093 | 0.005 | 0.093 | Purinergic P2X4 antagonist | |||
| 0.149 | 0.062 | 0.149 | MAP3K9 inhibitor | |||
| 0.11 | 0.023 | 0.129 | Na+ K+ transporting ATPase inhibitor | 0.129 0.012 CID_54264794 | CID_54264794 | |
| 0.102 | 0.016 | 0.102 | Beta adrenoreceptor antagonist | |||
| 0.1 | 0.015 | 0.1 | Androgen agonist | |||
| 0.1 | 0.015 | 0.1 | 5 Hydroxytryptamine 3 agonist | |||
| 0.1 | 0.016 | 0.1 | NMDA receptor glycine site agonist | |||
| 0.093 | 0.009 | 0.093 | Sphingosine kinase inhibitor | |||
| 0.112 | 0.029 | 0.112 | Cathepsin G inhibitor | |||
| 0.087 | 0.005 | 0.087 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.097 | 0.015 | 0.097 | Aryl hydrocarbon receptor antagonist | |||
| 0.112 | 0.029 | 0.112 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.086 | 0.003 | 0.086 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.136 | 0.054 | 0.136 | Proteasome inhibitor | |||
| 0.099 | 0.017 | 0.099 | Maillard reaction inhibitor | |||
| 0.111 | 0.029 | 0.111 | Bromodomain-containing protein 2 inhibitor | |||
| 0.093 | 0.013 | 0.093 | Exportin-1 inhibitor | |||
| 0.105 | 0.024 | 0.105 | Thioredoxin reductase inhibitor | |||
| 0.099 | 0.018 | 0.099 | Vanilloid 4 agonist | |||
| 0.099 | 0.019 | 0.099 | NMDA receptor agonist | |||
| 0.084 | 0.005 | 0.084 | Pregnane X receptor antagonist | |||
| 0.11 | 0.031 | 0.11 | Interleukin 5 antagonist | 0.1 0.042 CID_54264794 | ||
| 0.084 | 0.005 | 0.084 | Immunoglobulin Fc receptor antagonist | |||
| 0.104 | 0.025 | 0.104 | Dopamine agonist | |||
| 0.084 | 0.005 | 0.084 | Nicotinic acid receptor agonist | |||
| 0.128 | 0.05 | 0.128 | GABA receptor agonist | |||
| 0.083 | 0.005 | 0.083 | Catechol O-methyltransferase inhibitor | |||
| 0.184 | 0.106 | 0.404 | Hypolipemic | 0.404 0.024 CID_54264794 | CID_54264794 | |
| 0.125 | 0.048 | 0.125 | Nav1.4 sodium channel blocker | |||
| 0.087 | 0.01 | 0.087 | Calcium channel P-type blocker | |||
| 0.128 | 0.052 | 0.128 | Alpha 2b adrenoreceptor antagonist | |||
| 0.105 | 0.029 | 0.105 | Vanilloid agonist | |||
| 0.102 | 0.026 | 0.141 | Histone deacetylase stimulant | 0.141 0.011 CID_54264794 | CID_54264794 | |
| 0.102 | 0.026 | 0.141 | Histone deacetylase SIRT1 stimulant | 0.141 0.011 CID_54264794 | CID_54264794 | |
| 0.145 | 0.07 | 0.145 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.093 | 0.018 | 0.093 | 5 Hydroxytryptamine 2A agonist | |||
| 0.09 | 0.015 | 0.09 | Opioid mu receptor agonist | |||
| 0.082 | 0.008 | 0.082 | Beta 2 adrenoreceptor agonist | |||
| 0.086 | 0.013 | 0.086 | Glucosylceramidase inhibitor | 0.059 0.033 CID_54264794 | ||
| 0.19 | 0.117 | 0.19 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.144 | 0.072 | 0.144 | Activin receptor-like kinase 2 inhibitor | |||
| 0.084 | 0.011 | 0.084 | 5 Hydroxytryptamine 7 agonist | |||
| 0.083 | 0.01 | 0.083 | DNA helicase inhibitor | 0.052 0.044 CID_54264794 | ||
| 0.146 | 0.074 | 0.146 | MAP kinase 3 inhibitor | |||
| 0.086 | 0.014 | 0.086 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.102 | 0.03 | 0.102 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.09 | 0.02 | 0.09 | Protein kinase C eta inhibitor | |||
| 0.125 | 0.055 | 0.204 | DNA intercalator | 0.204 0.025 CID_54264794 | CID_54264794 | |
| 0.096 | 0.027 | 0.096 | Amidase inhibitor | |||
| 0.085 | 0.015 | 0.085 | Beta 1 adrenoreceptor antagonist | |||
| 0.14 | 0.071 | 0.14 | Cytokine production inhibitor | |||
| 0.126 | 0.058 | 0.126 | Protein kinase (CK2) alpha inhibitor | |||
| 0.078 | 0.01 | 0.089 | Adenine nucleotide translocase inhibitor | 0.089 0.006 CID_54264794 | CID_54264794 | |
| 0.128 | 0.06 | 0.128 | Acetylcholine muscarinic antagonist | |||
| 0.135 | 0.067 | 0.135 | Toll-Like receptor antagonist | |||
| 0.087 | 0.019 | 0.087 | Alpha 2 adrenoreceptor agonist | |||
| 0.074 | 0.006 | 0.074 | GABA uptake inhibitor | |||
| 0.075 | 0.008 | 0.075 | Liver X receptor alpha agonist | |||
| 0.083 | 0.015 | 0.083 | Cyclin D1 inhibitor | |||
| 0.082 | 0.014 | 0.082 | Plasminogen activator inhibitor antagonist | |||
| 0.079 | 0.012 | 0.237 | Alpha-mannosidase inhibitor | 0.237 0.003 CID_54264794 | CID_54264794 | |
| 0.08 | 0.012 | 0.08 | Beta 2 adrenoreceptor antagonist | |||
| 0.138 | 0.071 | 0.138 | Toll-Like receptor 9 antagonist | |||
| 0.098 | 0.031 | 0.098 | Caspase 7 inhibitor | |||
| 0.082 | 0.016 | 0.082 | Botulinum neurotoxin type A inhibitor | |||
| 0.078 | 0.012 | 0.078 | Potassium channel Kv1.3 blocker | |||
| 0.07 | 0.004 | 0.07 | ATP citrate lysase inhibitor | |||
| 0.072 | 0.007 | 0.072 | Geranyltranstransferase inhibitor | |||
| 0.069 | 0.005 | 0.074 | Guanylate cyclase inhibitor | 0.074 0.004 CID_54264794 | CID_54264794 | |
| 0.082 | 0.018 | 0.082 | MDM2 inhibitor | |||
| 0.079 | 0.015 | 0.079 | Heme oxygenase stimulant | |||
| 0.074 | 0.01 | 0.074 | CXC chemokine 1 receptor antagonist | |||
| 0.078 | 0.014 | 0.078 | Dopamine D2 agonist | |||
| 0.129 | 0.065 | 0.129 | Nav1.3 sodium channel blocker | |||
| 0.096 | 0.032 | 0.128 | Interferon agonist | 0.128 0.015 CID_54264794 | CID_54264794 | |
| 0.119 | 0.056 | 0.119 | Nav1.5 sodium channel blocker | |||
| 0.115 | 0.053 | 0.115 | Alpha 2c adrenoreceptor antagonist | |||
| 0.114 | 0.052 | 0.114 | Protein kinase (CK2) inhibitor | |||
| 0.146 | 0.085 | 0.417 | Thrombolytic | 0.417 0.01 CID_54264794 | CID_54264794 | |
| 0.157 | 0.095 | 0.157 | Lipocortins synthesis antagonist | 0.153 0.1 CID_54264794 | ||
| 0.068 | 0.006 | 0.068 | Glutamate (mGluR3) antagonist | |||
| 0.076 | 0.014 | 0.076 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.136 | 0.074 | 0.136 | Histone deacetylase SIRT1 inhibitor | |||
| 0.088 | 0.028 | 0.088 | Acetylcholine M5 receptor agonist | |||
| 0.079 | 0.018 | 0.079 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.158 | 0.098 | 0.496 | Platelet adhesion inhibitor | 0.496 0.005 CID_54264794 | CID_54264794 | |
| 0.165 | 0.105 | 0.165 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.066 | 0.006 | 0.066 | Nerve growth factor antagonist | |||
| 0.065 | 0.005 | 0.065 | Kainate receptor agonist | |||
| 0.071 | 0.011 | 0.245 | Mannosidase inhibitor | 0.245 0.003 CID_54264794 | CID_54264794 | |
| 0.111 | 0.052 | 0.111 | Gastric antisecretory | |||
| 0.126 | 0.068 | 0.126 | Glutamate receptor antagonist | |||
| 0.16 | 0.102 | 0.18 | P-glycoprotein inhibitor | 0.18 0.079 CID_54264794 | CID_54264794 | |
| 0.072 | 0.013 | 0.072 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.063 | 0.005 | 0.063 | Liver X receptor beta antagonist | |||
| 0.062 | 0.004 | 0.062 | Vanilloid 3 antagonist | |||
| 0.062 | 0.004 | 0.062 | CF transmembrane conductance regulator antagonist | |||
| 0.09 | 0.032 | 0.09 | Alpha adrenoreceptor agonist | |||
| 0.061 | 0.004 | 0.061 | Glutamate (mGluR1a) agonist | |||
| 0.066 | 0.009 | 0.066 | Fumarate hydratase inhibitor | 0.049 0.014 CID_54264794 | ||
| 0.072 | 0.016 | 0.072 | Lysine-specific demethylase 1A inhibitor | |||
| 0.066 | 0.01 | 0.066 | Glutamate (mGluR group III) antagonist | |||
| 0.062 | 0.006 | 0.062 | Glutamate (mGluR8) agonist | |||
| 0.07 | 0.014 | 0.07 | Leukotriene C antagonist | |||
| 0.065 | 0.009 | 0.065 | Dihydropteroate synthase inhibitor | |||
| 0.068 | 0.012 | 0.068 | Dihydroorotase inhibitor | |||
| 0.123 | 0.067 | 0.123 | Histone deacetylase class III inhibitor | |||
| 0.081 | 0.026 | 0.081 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.084 | 0.029 | 0.084 | Leukotriene antagonist | 0.079 0.033 CID_54264794 | ||
| 0.08 | 0.025 | 0.08 | TRPA1 antagonist | |||
| 0.074 | 0.019 | 0.074 | Glycine transporter 2 inhibitor | |||
| 0.071 | 0.017 | 0.071 | Epithelial sodium channel blocker | |||
| 0.064 | 0.01 | 0.064 | GABA B receptor antagonist | |||
| 0.056 | 0.003 | 0.056 | Estrogen-related receptor gamma antagonist | |||
| 0.065 | 0.012 | 0.065 | Urate transporter 1 inhibitor | |||
| 0.076 | 0.023 | 0.076 | Phosphodiesterase 1C inhibitor | |||
| 0.067 | 0.014 | 0.295 | Heparanase inhibitor | 0.295 0.002 CID_54264794 | CID_54264794 | |
| 0.081 | 0.027 | 0.081 | Potassium channel (ATP-sensitive) blocker | |||
| 0.087 | 0.034 | 0.087 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.086 | 0.033 | 0.095 | Phosphodiesterase VI inhibitor | 0.095 0.023 CID_54264794 | CID_54264794 | |
| 0.068 | 0.016 | 0.068 | Carbonic anhydrase VII inhibitor | |||
| 0.079 | 0.026 | 0.079 | Carbonic anhydrase stimulant | |||
| 0.071 | 0.019 | 0.115 | Leukotriene B4 antagonist | 0.115 0.008 CID_54264794 | CID_54264794 | |
| 0.074 | 0.021 | 0.074 | Opioid agonist | |||
| 0.079 | 0.027 | 0.079 | Acetylcholine M3 receptor antagonist | |||
| 0.061 | 0.009 | 0.061 | Sirtuin 2 inhibitor | |||
| 0.077 | 0.026 | 0.101 | Interferon inducer | 0.101 0.012 CID_54264794 | CID_54264794 | |
| 0.096 | 0.045 | 0.143 | ATPase (Vacuolar H+) inhibitor | 0.143 0.009 CID_54264794 | CID_54264794 | |
| 0.1 | 0.05 | 0.1 | ABCA1 expression enhancer | |||
| 0.063 | 0.013 | 0.063 | Glutamate (mGluR4) antagonist | |||
| 0.083 | 0.033 | 0.083 | Secretase beta inhibitor | |||
| 0.116 | 0.066 | 0.116 | Interleukin 1b antagonist | |||
| 0.064 | 0.014 | 0.064 | Oxytocin agonist | |||
| 0.097 | 0.049 | 0.097 | Phosphodiesterase I inhibitor | |||
| 0.092 | 0.045 | 0.092 | Inducible nitric-oxide synthase inhibitor | |||
| 0.059 | 0.011 | 0.059 | Retinoid X alpha receptor agonist | |||
| 0.063 | 0.015 | 0.068 | Factor III inhibitor | 0.068 0.012 CID_54264794 | CID_54264794 | |
| 0.061 | 0.014 | 0.061 | AICAR transformylase inhibitor | |||
| 0.063 | 0.016 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.058 | 0.011 | 0.058 | AMPA 4 receptor antagonist | |||
| 0.054 | 0.007 | 0.069 | Uridine phosphorylase inhibitor | 0.069 0.004 CID_54264794 | CID_54264794 | |
| 0.057 | 0.01 | 0.057 | Beta adrenoreceptor agonist | |||
| 0.097 | 0.05 | 0.097 | Calcium antagonist | |||
| 0.055 | 0.009 | 0.055 | Heme oxygenase inhibitor | |||
| 0.122 | 0.076 | 0.122 | M17 leucyl aminopeptidase inhibitor | |||
| 0.048 | 0.003 | 0.048 | Nicotinic acid receptor 1 antagonist | |||
| 0.049 | 0.004 | 0.049 | Alpha 2a adrenoreceptor agonist | |||
| 0.07 | 0.026 | 0.07 | Ornithine carbamoyltransferase inhibitor | 0.046 0.044 CID_54264794 | ||
| 0.239 | 0.194 | 0.239 | Transcription factor inhibitor | |||
| 0.056 | 0.012 | 0.056 | Sphingosine kinase 1 inhibitor | |||
| 0.052 | 0.008 | 0.052 | Free fatty acid receptor 1 antagonist | |||
| 0.085 | 0.041 | 0.085 | Metalloproteinase-9 inhibitor | |||
| 0.058 | 0.015 | 0.08 | Cytokine production stimulant | 0.08 0.005 CID_54264794 | CID_54264794 | |
| 0.064 | 0.02 | 0.126 | Glucose-6-phosphate translocase inhibitor | 0.126 0.004 CID_54264794 | CID_54264794 | |
| 0.159 | 0.116 | 0.159 | Focal adhesion kinase 2 inhibitor | |||
| 0.058 | 0.015 | 0.058 | Retinoid X receptor agonist | |||
| 0.048 | 0.005 | 0.048 | Glutamate (mGluR3) agonist | |||
| 0.053 | 0.01 | 0.053 | Liver X receptor beta agonist | |||
| 0.049 | 0.006 | 0.136 | Sodium/glucose cotransporter 2 inhibitor | 0.136 0.002 CID_54264794 | CID_54264794 | |
| 0.062 | 0.019 | 0.062 | Adenosine deaminase inhibitor | 0.059 0.022 CID_54264794 | ||
| 0.055 | 0.012 | 0.055 | Phosphoglycerate kinase inhibitor | |||
| 0.05 | 0.007 | 0.05 | Protein kinase (CK2) beta inhibitor | |||
| 0.06 | 0.018 | 0.06 | Cholesterol esterase inhibitor | |||
| 0.129 | 0.087 | 0.129 | CDC-like kinase 1 inhibitor | |||
| 0.069 | 0.027 | 0.069 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.059 | 0.018 | 0.059 | Thymidylate synthase inhibitor | |||
| 0.078 | 0.037 | 0.078 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.049 | 0.008 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.049 0.008 CID_54264794 | ||
| 0.24 | 0.199 | 0.24 | DNA polymerase beta inhibitor | |||
| 0.053 | 0.013 | 0.053 | Estrogen-related receptor alpha antagonist | |||
| 0.081 | 0.041 | 0.081 | Adenosine A3 receptor antagonist | |||
| 0.051 | 0.011 | 0.051 | Delayed rectifier potassium channel blocker | |||
| 0.095 | 0.054 | 0.095 | Potassium channel activator | |||
| 0.076 | 0.037 | 0.076 | Carbonic anhydrase inhibitor | 0.072 0.039 CID_54264794 | ||
| 0.069 | 0.029 | 0.13 | Carbonic anhydrase XII inhibitor | 0.13 0.015 CID_54264794 | CID_54264794 | |
| 0.086 | 0.047 | 0.086 | Metalloproteinase-2 inhibitor | |||
| 0.079 | 0.04 | 0.079 | Prostaglandin-E synthase inhibitor | |||
| 0.059 | 0.02 | 0.059 | Dopamine D5 antagonist | |||
| 0.052 | 0.013 | 0.052 | Diamine oxidase inhibitor | |||
| 0.084 | 0.045 | 0.084 | Alpha 2a adrenoreceptor antagonist | |||
| 0.051 | 0.013 | 0.051 | Opioid delta receptor agonist | |||
| 0.069 | 0.03 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.116 | 0.078 | 0.116 | Cholinergic antagonist | |||
| 0.051 | 0.013 | 0.051 | RNA-directed RNA polymerase inhibitor | |||
| 0.063 | 0.025 | 0.063 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.07 | 0.032 | 0.07 | I kappa B kinase 2 inhibitor | |||
| 0.059 | 0.021 | 0.059 | Oleamide hydrolase inhibitor | |||
| 0.068 | 0.031 | 0.068 | Histone deacetylase SIRT3 inhibitor | |||
| 0.042 | 0.004 | 0.042 | Hedgehog signaling activator | |||
| 0.042 | 0.005 | 0.042 | Thyroid hormone agonist | |||
| 0.041 | 0.005 | 0.041 | Nicotinic acid receptor 2 antagonist | |||
| 0.06 | 0.025 | 0.06 | AMPA receptor antagonist | |||
| 0.068 | 0.033 | 0.068 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.075 | 0.04 | 0.075 | Elastase 1 inhibitor | |||
| 0.06 | 0.025 | 0.19 | Phosphorylase inhibitor | 0.19 0.005 CID_54264794 | CID_54264794 | |
| 0.112 | 0.078 | 0.112 | Acetylcholine antagonist | |||
| 0.068 | 0.033 | 0.086 | Carbonic anhydrase IX inhibitor | 0.086 0.024 CID_54264794 | CID_54264794 | |
| 0.043 | 0.009 | 0.043 | Dopamine autoreceptor agonist | |||
| 0.198 | 0.164 | 0.198 | Thyroid hormone antagonist | |||
| 0.076 | 0.042 | 0.076 | Purinergic P2X2 antagonist | |||
| 0.087 | 0.053 | 0.087 | GABA A receptor agonist | |||
| 0.235 | 0.201 | 0.235 | DNA directed DNA polymerase inhibitor | |||
| 0.043 | 0.01 | 0.043 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.128 | 0.094 | 0.128 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.04 | 0.007 | 0.148 | Sodium/glucose cotransporter inhibitor | 0.148 0.002 CID_54264794 | CID_54264794 | |
| 0.049 | 0.016 | 0.085 | Arginase inhibitor | 0.085 0.005 CID_54264794 | CID_54264794 | |
| 0.047 | 0.015 | 0.047 | Retinoid X receptor antagonist | |||
| 0.049 | 0.017 | 0.049 | Kinesin-like protein 1 inhibitor | |||
| 0.049 | 0.017 | 0.049 | Kinesin antagonist | |||
| 0.04 | 0.007 | 0.04 | Purinergic P2Y15 antagonist | |||
| 0.041 | 0.009 | 0.041 | Liver X receptor alpha antagonist | |||
| 0.037 | 0.005 | 0.06 | Vanilloid 2 agonist | 0.06 0.002 CID_54264794 | CID_54264794 | |
| 0.073 | 0.041 | 0.073 | Sirtuin 1 inhibitor | |||
| 0.056 | 0.024 | 0.056 | Potassium channel (Inward rectifier) activator | |||
| 0.046 | 0.014 | 0.046 | Leukotriene C4 antagonist | |||
| 0.052 | 0.02 | 0.052 | CDK5/p25 inhibitor | |||
| 0.097 | 0.065 | 0.097 | Nitric-oxide synthase inhibitor | |||
| 0.035 | 0.004 | 0.035 | Estrogen-related receptor gamma agonist | |||
| 0.07 | 0.039 | 0.07 | Neutrophil collagenase inhibitor | |||
| 0.066 | 0.035 | 0.066 | Acetylcholine M5 receptor antagonist | |||
| 0.043 | 0.012 | 0.043 | HCV NS5B polymerase inhibitor | |||
| 0.043 | 0.012 | 0.043 | Liver X receptor antagonist | |||
| 0.042 | 0.011 | 0.042 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.049 | 0.019 | 0.049 | Angiotensin AT1 receptor antagonist | |||
| 0.034 | 0.004 | 0.034 | NMDA receptor phencyclidine site antagonist | |||
| 0.053 | 0.024 | 0.053 | Potassium channel (ATP-sensitive) activator | |||
| 0.065 | 0.036 | 0.065 | Phosphodiesterase 1B inhibitor | |||
| 0.034 | 0.005 | 0.034 | Complement factor 1s inhibitor | |||
| 0.048 | 0.019 | 0.048 | DNA gyrase subunit A inhibitor | |||
| 0.039 | 0.011 | 0.039 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.038 | 0.009 | 0.038 | CXC chemokine 2 receptor antagonist | |||
| 0.132 | 0.103 | 0.132 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.032 | 0.003 | 0.051 | Antibiotic Anthracycline-like | 0.051 0.002 CID_54264794 | CID_54264794 | |
| 0.056 | 0.028 | 0.056 | Vanilloid 2 antagonist | |||
| 0.035 | 0.007 | 0.035 | Prostaglandin F2 alpha agonist | |||
| 0.051 | 0.023 | 0.051 | Glutamate (mGluR group III) agonist | |||
| 0.048 | 0.02 | 0.048 | Thymidine kinase inhibitor | |||
| 0.034 | 0.007 | 0.039 | Dopamine D1 agonist | 0.039 0.005 CID_54264794 | CID_54264794 | |
| 0.062 | 0.034 | 0.062 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.058 | 0.031 | 0.058 | Thromboxane synthase inhibitor | |||
| 0.04 | 0.013 | 0.04 | Melatonin receptor 1A agonist | |||
| 0.061 | 0.034 | 0.061 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.062 | 0.035 | 0.062 | Ribonucleotide reductase inhibitor | |||
| 0.083 | 0.056 | 0.083 | I kappa B kinase inhibitor | |||
| 0.089 | 0.063 | 0.089 | Protein kinase C delta inhibitor | |||
| 0.046 | 0.02 | 0.046 | Progesterone antagonist | |||
| 0.055 | 0.028 | 0.055 | Potassium channel (Inward rectifier) blocker | |||
| 0.055 | 0.029 | 0.055 | Prolyl endopeptidase inhibitor | |||
| 0.041 | 0.015 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.033 | 0.008 | 0.033 | Glutamate (mGluR1) agonist | |||
| 0.085 | 0.06 | 0.085 | Alpha 2 adrenoreceptor antagonist | |||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase II inhibitor | 0.05 0.044 CID_54264794 | ||
| 0.07 | 0.045 | 0.07 | Neuronal nicotinic receptor antagonist | |||
| 0.044 | 0.019 | 0.044 | 5 Hydroxytryptamine 2B agonist | |||
| 0.087 | 0.063 | 0.087 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.061 | 0.037 | 0.061 | Dopamine uptake inhibitor | |||
| 0.055 | 0.032 | 0.055 | 5 Hydroxytryptamine 2 agonist | |||
| 0.074 | 0.051 | 0.074 | Potassium channel (Tandem pore domain) blocker | |||
| 0.043 | 0.02 | 0.043 | Farnesoid X receptor agonist | |||
| 0.039 | 0.016 | 0.039 | Retinoid X alpha receptor antagonist | |||
| 0.063 | 0.04 | 0.063 | Prolactin release inhibitor | |||
| 0.042 | 0.02 | 0.042 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.037 | 0.014 | 0.037 | Protein kinase C beta I inhibitor | 0.032 0.029 CID_54264794 | ||
| 0.048 | 0.026 | 0.048 | Carbonic anhydrase IV inhibitor | |||
| 0.046 | 0.024 | 0.046 | Kainate receptor antagonist | |||
| 0.041 | 0.019 | 0.041 | Integrin alpha2 antagonist | |||
| 0.046 | 0.024 | 0.046 | Erythropoietin receptor agonist | |||
| 0.078 | 0.057 | 0.078 | Acetylcholine nicotinic antagonist | |||
| 0.029 | 0.008 | 0.029 | Imidazoline I1 receptor antagonist | |||
| 0.038 | 0.017 | 0.038 | Angiotensin II receptor antagonist | |||
| 0.035 | 0.014 | 0.035 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.025 0.022 CID_54264794 | ||
| 0.052 | 0.031 | 0.052 | Bombesin 2 receptor antagonist | |||
| 0.04 | 0.02 | 0.04 | Nicotinic acid receptor 2 agonist | |||
| 0.031 | 0.011 | 0.031 | Thymidine phosphorylase inhibitor | |||
| 0.079 | 0.059 | 0.079 | Acetylcholine nicotinic agonist | |||
| 0.058 | 0.038 | 0.058 | Alpha 1 adrenoreceptor agonist | |||
| 0.047 | 0.027 | 0.047 | Opioid kappa receptor agonist | |||
| 0.027 | 0.008 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 CID_54264794 | ||
| 0.064 | 0.044 | 0.14 | Neuraminidase (influenza) inhibitor | 0.14 0.009 CID_54264794 | CID_54264794 | |
| 0.025 | 0.006 | 0.065 | Ileal bile acid transport inhibitor | 0.065 0.003 CID_54264794 | CID_54264794 | |
| 0.057 | 0.038 | 0.057 | Carbonic anhydrase I inhibitor | 0.05 0.043 CID_54264794 | ||
| 0.03 | 0.011 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.025 | 0.007 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.028 | 0.009 | 0.028 | Beta 1 adrenoreceptor agonist | |||
| 0.028 | 0.01 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.04 | 0.022 | 0.04 | Potassium channel Kv1.1 blocker | |||
| 0.048 | 0.03 | 0.048 | Benzodiazepine antagonist | |||
| 0.023 | 0.005 | 0.032 | Telomerase stimulant | 0.032 0.003 CID_54264794 | CID_54264794 | |
| 0.055 | 0.037 | 0.055 | GABA receptor antagonist | |||
| 0.035 | 0.017 | 0.035 | Protein kinase C beta II inhibitor | |||
| 0.035 | 0.017 | 0.035 | AMPA 3 receptor antagonist | |||
| 0.024 | 0.006 | 0.024 | Alpha 2b adrenoreceptor agonist | |||
| 0.027 | 0.01 | 0.027 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.021 | 0.004 | 0.021 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.232 | 0.215 | 0.232 | MAP kinase kinase 6 inhibitor | |||
| 0.059 | 0.042 | 0.059 | Phosphodiesterase 1A inhibitor | |||
| 0.034 | 0.017 | 0.034 | Prostaglandin agonist | |||
| 0.029 | 0.013 | 0.029 | Prostaglandin EP2 agonist | |||
| 0.029 | 0.012 | 0.029 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.03 | 0.013 | 0.03 | Integrin alpha2beta1 antagonist | |||
| 0.039 | 0.023 | 0.039 | Kainate receptor 2 antagonist | |||
| 0.045 | 0.028 | 0.045 | Histamine H1 receptor agonist | |||
| 0.031 | 0.015 | 0.031 | Lysine carboxypeptidase inhibitor | |||
| 0.026 | 0.01 | 0.026 | ICAM 1 antagonist | |||
| 0.024 | 0.009 | 0.024 | Neuraminidase (Influenza B) inhibitor | |||
| 0.029 | 0.013 | 0.029 | NMDA receptor glycine site antagonist | |||
| 0.044 | 0.029 | 0.044 | Dihydrofolate reductase inhibitor | |||
| 0.031 | 0.016 | 0.031 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.019 CID_54264794 | ||
| 0.042 | 0.026 | 0.042 | Acid-sensing ion channel blocker | |||
| 0.029 | 0.014 | 0.029 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.04 | 0.025 | 0.04 | MAP3K5 inhibitor | |||
| 0.04 | 0.025 | 0.04 | Histone deacetylase 9 inhibitor | |||
| 0.04 | 0.025 | 0.04 | Glutamate (mGluR group II) antagonist | |||
| 0.034 | 0.019 | 0.034 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.145 | 0.13 | 0.145 | Death-associated protein kinase 3 inhibitor | |||
| 0.053 | 0.038 | 0.053 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.035 | 0.021 | 0.035 | Glutamate (mGluR4) agonist | |||
| 0.042 | 0.027 | 0.042 | Plasmepsin II inhibitor | |||
| 0.019 | 0.004 | 0.019 | Egl nine homolog 3 inhibitor | |||
| 0.097 | 0.083 | 0.131 | Multidrug resistance-associated protein 1 inhibitor | 0.131 0.038 CID_54264794 | CID_54264794 | |
| 0.039 | 0.025 | 0.039 | 5-Alpha-reductase inhibitor | |||
| 0.043 | 0.029 | 0.043 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.03 | 0.016 | 0.03 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.019 | 0.006 | 0.019 | Egl nine homolog 1 inhibitor | |||
| 0.107 | 0.094 | 0.107 | Acetylcholinesterase inhibitor | |||
| 0.073 | 0.06 | 0.073 | Glutamate receptor agonist | |||
| 0.027 | 0.014 | 0.027 | Acid ceramidase inhibitor | |||
| 0.05 | 0.037 | 0.05 | Cannabinoid CB2 receptor antagonist | |||
| 0.047 | 0.034 | 0.047 | Aldosterone antagonist | |||
| 0.052 | 0.039 | 0.052 | GABA A receptor antagonist | |||
| 0.063 | 0.05 | 0.063 | Matrix metalloproteinase inhibitor | |||
| 0.029 | 0.017 | 0.029 | NMDA 2D receptor antagonist | |||
| 0.044 | 0.032 | 0.044 | Purinergic P2Y antagonist | |||
| 0.044 | 0.031 | 0.044 | Sphingosine 1-phosphate receptor agonist | |||
| 0.031 | 0.019 | 0.031 | Glucagon receptor antagonist | |||
| 0.022 | 0.01 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.019 | 0.007 | 0.019 | Thromboxane A2 agonist | |||
| 0.029 | 0.017 | 0.029 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.032 | 0.02 | 0.032 | Cholesterol ester transfer protein antagonist | |||
| 0.03 | 0.018 | 0.03 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.038 | 0.027 | 0.038 | TRPM8 blocker | |||
| 0.182 | 0.171 | 0.182 | Thyroid hormone beta antagonist | |||
| 0.051 | 0.04 | 0.051 | Thromboxane antagonist | |||
| 0.034 | 0.023 | 0.034 | Calcitonin receptor agonist | |||
| 0.082 | 0.072 | 0.082 | Pim-3 kinase inhibitor | |||
| 0.109 | 0.098 | 0.109 | Sodium channel (voltage-gated) blocker | |||
| 0.016 | 0.005 | 0.016 | Glutamate (mGluR6) agonist | |||
| 0.042 | 0.032 | 0.042 | Liver X receptor agonist | |||
| 0.048 | 0.038 | 0.048 | Thromboxane A2 antagonist | |||
| 0.026 | 0.017 | 0.026 | Prostaglandin H2 antagonist | |||
| 0.042 | 0.032 | 0.042 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.077 | 0.068 | 0.077 | Bcr-Abl kinase inhibitor | |||
| 0.038 | 0.029 | 0.038 | Membrane dipeptidase inhibitor | |||
| 0.02 | 0.011 | 0.02 | Alpha 2c adrenoreceptor agonist | |||
| 0.023 | 0.014 | 0.026 | Leukotriene B4 receptor 2 antagonist | 0.026 0.011 CID_54264794 | CID_54264794 | |
| 0.013 | 0.004 | 0.013 | Progesterone receptor A antagonist | |||
| 0.024 | 0.015 | 0.024 | Prostaglandin E2 agonist | |||
| 0.019 | 0.011 | 0.019 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.021 | 0.012 | 0.021 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.039 | 0.031 | 0.039 | Histone deacetylase 8 inhibitor | |||
| 0.017 | 0.009 | 0.017 | Purinergic P2Y1 agonist | |||
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | |||
| 0.022 | 0.015 | 0.022 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.016 | 0.009 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.034 | 0.028 | 0.034 | Histone deacetylase 7 inhibitor | |||
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | |||
| 0.015 | 0.008 | 0.015 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.01 | 0.004 | 0.01 | DNA topoisomerase III inhibitor | |||
| 0.046 | 0.041 | 0.046 | Matrix metalloproteinase 1 inhibitor | |||
| 0.07 | 0.065 | 0.286 | Antineoplastic antibiotic | 0.286 0.01 CID_54264794 | CID_54264794 | |
| 0.01 | 0.005 | 0.01 | Thyroid hormone beta agonist | |||
| 0.027 | 0.022 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 CID_54264794 | CID_54264794 | |
| 0.055 | 0.05 | 0.076 | Lipocortins synthesis agonist | 0.076 0.016 CID_54264794 | CID_54264794 | |
| 0.077 | 0.072 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.027 | 0.023 | 0.027 | 5 Hydroxytryptamine 6 agonist | |||
| 0.015 | 0.011 | 0.015 | Thyroid hormone alpha antagonist | |||
| 0.026 | 0.021 | 0.026 | Leukotriene B4 receptor 1 antagonist | |||
| 0.017 | 0.012 | 0.017 | G-protein-coupled receptor 120 agonist | |||
| 0.026 | 0.022 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.016 | 0.012 | 0.016 | Thyroid hormone alpha agonist | |||
| 0.021 | 0.016 | 0.021 | Estrone sulfatase inhibitor | |||
| 0.05 | 0.046 | 0.05 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.057 | 0.053 | 0.057 | Prostaglandin F2 alpha antagonist | |||
| 0.026 | 0.022 | 0.026 | Cyclin E2 inhibitor | |||
| 0.025 | 0.021 | 0.025 | Calcium-sensing receptor agonist | |||
| 0.055 | 0.052 | 0.055 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.017 | 0.015 | 0.017 | Complement factor D inhibitor | |||
| 0.051 | 0.048 | 0.051 | Adenosine A1 receptor antagonist | |||
| 0.006 | 0.004 | 0.006 | Insulin like growth factor 3 antagonist | |||
| 0.053 | 0.051 | 0.053 | Acetylcholine M2 receptor antagonist | |||
| 0.027 | 0.025 | 0.027 | Glutamate (mGluR2) antagonist | |||
| 0.093 | 0.091 | 0.093 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.006 | 0.004 | 0.006 | Transcortin receptor antagonist | |||
| 0.015 | 0.013 | 0.015 | Adenosine A2 receptor agonist | |||
| 0.053 | 0.052 | 0.053 | Collagenase 3 inhibitor | |||
| 0.025 | 0.023 | 0.025 | AMPA 1 receptor antagonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.094 | 0.093 | 0.094 | CDC-like kinase 3 inhibitor | |||
| 0.01 | 0.009 | 0.01 | Thromboxane agonist | |||
| 0.059 | 0.058 | 0.059 | Cyclin B3 inhibitor | |||
| 0.085 | 0.084 | 0.085 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.009 | 0.009 | 0.015 | Purinergic P2Y2 agonist | 0.015 0.003 CID_54264794 | CID_54264794 | |
| 0.015 | 0.014 | 0.015 | Carbonic anhydrase X inhibitor | |||
| 0.015 | 0.014 | 0.015 | Carbonic anhydrase VIII inhibitor | |||
| 0.045 | 0.047 | 0.129 | Factor IXa inhibitor | 0.129 0.005 CID_54264794 | CID_54264794 | |
| 0.051 | 0.058 | 0.494 | Selectin antagonist | 0.494 0.003 CID_54264794 | CID_54264794 | |
| 0.047 | 0.056 | 0.075 | Prostaglandin EP2 antagonist | 0.075 0.03 CID_54264794 | CID_54264794 | |
| 0.049 | 0.059 | 0.115 | Neuraminidase inhibitor | 0.115 0.011 CID_54264794 | CID_54264794 | |
| 0.075 | 0.089 | 0.118 | T cell inhibitor | 0.118 0.015 CID_54264794 | CID_54264794 | |
| 0.017 | 0.035 | 0.081 | Protein 30S ribosomal subunit inhibitor | 0.081 0.004 CID_54264794 | CID_54264794 | |
| 0.012 | 0.044 | 0.023 | Corticosteroid-like | 0.023 0.013 CID_54264794 | CID_54264794 | |
| 0.064 | 0.097 | 0.137 | Falcipain 2 inhibitor | 0.137 0.034 CID_54264794 | CID_54264794 | |
| 0.066 | 0.099 | 0.14 | Falcipain inhibitor | 0.14 0.035 CID_54264794 | CID_54264794 | |
| 0.069 | 0.103 | 0.195 | Transcription factor NF kappa B stimulant | 0.195 0.009 CID_54264794 | CID_54264794 | |
| 0.014 | 0.048 | 0.067 | Squalene synthetase inhibitor | 0.067 0.01 CID_54264794 | CID_54264794 | |
| 0.046 | 0.081 | 0.066 | Transcription factor AP-1 inhibitor | 0.066 0.036 CID_54264794 | CID_54264794 | |
| 0.03 | 0.074 | 0.068 | Neuraminidase (Influenza A) inhibitor | 0.068 0.008 CID_54264794 | CID_54264794 | |
| 0.003 | 0.054 | 0.013 | Purinergic receptor agonist | 0.013 0.012 CID_54264794 | CID_54264794 | |
| 0.003 | 0.054 | 0.013 | Purinergic P2 agonist | 0.013 0.012 CID_54264794 | CID_54264794 | |
| 0.018 | 0.083 | 0.048 | Factor Xa inhibitor | 0.048 0.031 CID_54264794 | CID_54264794 | |
| 0.007 | 0.076 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.011 CID_54264794 | CID_54264794 | |
| 0.022 | 0.104 | 0.099 | Antibiotic Aminoglycoside-like | 0.099 0.003 CID_54264794 | CID_54264794 | |
| 0.002 | 0.095 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 CID_54264794 | CID_54264794 | |
| 0.017 | 0.112 | 0.041 | Toll-Like receptor 4 agonist | 0.041 0.005 CID_54264794 | CID_54264794 | |
| 0.071 | 0.171 | 0.092 | Folate antagonist | 0.092 0.082 CID_54264794 | CID_54264794 | |
| 0.024 | 0.125 | 0.055 | Microtubule stabilization | 0.055 0.021 CID_54264794 | CID_54264794 | |
| 0.021 | 0.139 | 0.15 | Protein 50S ribosomal subunit inhibitor | 0.15 0.007 CID_54264794 | CID_54264794 | |
| 0.071 | 0.189 | 0.419 | Cell adhesion inhibitor | 0.419 0.005 CID_54264794 | CID_54264794 | |
| 0.023 | 0.178 | 0.083 | Nitric oxide donor | 0.083 0.019 CID_54264794 | CID_54264794 | |
| 0.089 | 0.244 | 0.403 | Platelet antagonist | 0.403 0.026 CID_54264794 | CID_54264794 | |
| 0.042 | 0.231 | 0.242 | Cell adhesion molecule inhibitor | 0.242 0.007 CID_54264794 | CID_54264794 | |
| 0.101 | 0.331 | 0.333 | Angiogenesis inhibitor | 0.333 0.078 CID_54264794 | CID_54264794 | |
| 0.006 | 0.271 | 0.033 | Motilin receptor agonist | 0.033 0.009 CID_54264794 | CID_54264794 | |
| 0.016 | 0.306 | 0.073 | DNA gyrase inhibitor | 0.073 0.033 CID_54264794 | CID_54264794 | |
| 0.085 | 0.405 | 0.306 | Antiobesity | 0.306 0.112 CID_54264794 | CID_54264794 | |
| 0.005 | 0.339 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.01 CID_54264794 | CID_54264794 | |
| 0.035 | 0.386 | 0.316 | Anticoagulant | 0.316 0.026 CID_54264794 | CID_54264794 | |
| 0.07 | 0.481 | 0.548 | Immunomodulator | 0.548 0.017 CID_54264794 | CID_54264794 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |